The Impact of an Incidental Dose on Axillary Tumor Control and Toxicity in Localized Breast Cancer: A Retrospective Analysis.

axillary lymph node breast carcinoma dosimetric analysis intensity-modulated radiotherapy radiotherapy three-dimensional radiotherapy

Journal

Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829

Informations de publication

Date de publication:
04 Feb 2022
Historique:
received: 16 12 2021
revised: 28 01 2022
accepted: 01 02 2022
entrez: 15 2 2022
pubmed: 16 2 2022
medline: 16 2 2022
Statut: epublish

Résumé

The dosimetric analysis of the incidental axillary dose delivered to axillary lymph node levels I-III by different techniques of whole breast irradiation and the analysis of prognostic factors of axillary recurrence of breast cancer. We perform a retrospective analysis that includes 171 patients with localized breast carcinoma irradiated at Centre Paul Strauss. To be included in the study, patients had to have a histological confirmation of breast cancer diagnosis, surgical treatment without axillary lymph node dissection (ALND), whole breast irradiation without axillary irradiation by a specific field, and a treatment plan available. Three patients had lymph node recurrence. There was no significant correlation between the maximal or mean dose delivered at the three axillary levels and the risk of axillary lymph node recurrence. There was no significant correlation between the irradiation technique and the risk of axillary lymph node recurrence. Two patients, both in the HT group, had lymphoedema. There was significantly more lymphoedema in the HT group than in the ST and IMRT groups ( The irradiation technique has an influence on the incidental dose delivered to the axillary area, but has no influence on the risk of axillary recurrence. The risk of lymphoedema could be related to the use of HT and the mean dose delivered at level II.

Identifiants

pubmed: 35159074
pii: cancers14030807
doi: 10.3390/cancers14030807
pmc: PMC8834453
pii:
doi:

Types de publication

Journal Article

Langues

eng

Références

JAMA. 2017 Sep 12;318(10):918-926
pubmed: 28898379
Comput Med Imaging Graph. 2016 Dec;54:1-5
pubmed: 27838084
Int J Radiat Oncol Biol Phys. 2014 Mar 1;88(3):565-71
pubmed: 24411624
Int J Radiat Oncol Biol Phys. 2009 Mar 1;73(3):944-51
pubmed: 19215827
J Clin Oncol. 2013 Dec 20;31(36):4488-95
pubmed: 24043742
Strahlenther Onkol. 2021 Sep;197(9):820-828
pubmed: 34292348
Medicine (Baltimore). 2016 Jun;95(26):e4036
pubmed: 27368030
Cancer Radiother. 2021 Jun 23;:
pubmed: 34175223
Int J Radiat Oncol Biol Phys. 2018 Sep 1;102(1):71-78
pubmed: 30102206
Int J Radiat Oncol Biol Phys. 2006 May 1;65(1):284-90
pubmed: 16618583
Int J Radiat Oncol Biol Phys. 2008 Dec 1;72(5):1449-55
pubmed: 19028274
Breast Cancer Res Treat. 2006 Feb;95(3):279-93
pubmed: 16163445
Ned Tijdschr Geneeskd. 2015;159:A9302
pubmed: 26488192
Int J Radiat Oncol Biol Phys. 1999 Jul 15;44(5):1155-64
pubmed: 10421550
Int J Radiat Oncol Biol Phys. 2005 Jan 1;61(1):163-8
pubmed: 15629607
Curr Probl Surg. 2016 Dec;53(12):559-595
pubmed: 28160790
Br J Surg. 2011 Mar;98(3):326-33
pubmed: 21254004
J Surg Oncol. 2010 Aug 1;102(2):111-8
pubmed: 20648579
Br J Radiol. 2010 Dec;83(996):1072-6
pubmed: 21088091
Radiother Oncol. 2015 Jan;114(1):3-10
pubmed: 25630428
N Engl J Med. 2002 Oct 17;347(16):1233-41
pubmed: 12393820
Radiother Oncol. 2020 Jan;142:195-201
pubmed: 31540747
Eur J Surg Oncol. 2015 Aug;41(8):958-66
pubmed: 26054706
Radiat Oncol J. 2018 Mar;36(1):71-78
pubmed: 29621872
Ann Surg Oncol. 2014 Nov;21(12):3758-65
pubmed: 25096388
Radiother Oncol. 2009 Oct;93(1):71-9
pubmed: 19682758

Auteurs

Martin Schmitt (M)

Radiotherapy Department, Strasbourg Europe Cancer Institute, 17 Rue Albert Calmette, 67200 Strasbourg, France.

Isabelle Chambrelant (I)

Radiotherapy Department, Strasbourg Europe Cancer Institute, 17 Rue Albert Calmette, 67200 Strasbourg, France.

Parigna Hong Chheang (P)

Radiotherapy Department, Khmer Soviet Friendship Hospital, Yuthapol Khemarak Phoumin Blvd, Phnom Penh 12306, Cambodia.

Carole Pflumio (C)

Medical Oncology Department, Strasbourg Europe Cancer Institute, 17 Rue Albert Calmette, 67200 Strasbourg, France.

Carole Hild (C)

Breast Surgery Department, Strasbourg Europe Cancer Institute, 17 Rue Albert Calmette, 67200 Strasbourg, France.

Thierry Petit (T)

Medical Oncology Department, Strasbourg Europe Cancer Institute, 17 Rue Albert Calmette, 67200 Strasbourg, France.

Georges Noël (G)

Radiotherapy Department, Strasbourg Europe Cancer Institute, 17 Rue Albert Calmette, 67200 Strasbourg, France.

Classifications MeSH